Sri Ganapathi Drug Intermediates Private Limited
Specializes in trading and manufacturing of various chemicals for industrial, pharmaceutical, and other purposes.
2010 | Hyderabad, Telangana (India) | Active
Sri Ganapathi Drug Intermediates Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 23.45 Cr
- Revenue Growth -19.95%
- Profit Growth 33.82%
- Ebitda 192.63%
- Net Worth -0.72%
- Total Assets -10.76%
About Sri Ganapathi Drug Intermediates
Sri Ganapathi Drug Intermediates Private Limited (SGDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2010 and has a history of 14 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹23.45 Cr.
Koti Tatikonda, Venkata Jogi, and Sai Thatikonda serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2010PTC070402
- Company No.
070402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals and Materials
Sri Ganapathi Drug Intermediates Private Limited
Explore comprehensive data for Sri Ganapathi Drug Intermediates Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sri Ganapathi Drug Intermediates?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koti Tatikonda  | Director | 10-Sep-2010 | Current |
| Venkata Jogi | Additional Director | 30-Mar-2015 | Current |
| Sai Thatikonda | Director | 03-Jul-2023 | Current |
Financial Performance of Sri Ganapathi Drug Intermediates.
Sri Ganapathi Drug Intermediates Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.95% decrease. The company also saw a substantial improvement in profitability, with a 33.82% increase in profit. The company's net worth dipped by a decrease of 0.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Ganapathi Drug Intermediates?
In 2019, Sri Ganapathi Drug Intermediates had a promoter holding of 27.00% and a public holding of 73.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Krishnaveni Constructions Private Limited
Koti Tatikonda is a mutual person
Charges (Loans)
Open Charges
₹23.45 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 23.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2016 | State Bank Of India | ₹2.25 Cr | Open |
| 18 Apr 2013 | State Bank Of India | ₹9.00 Cr | Open |
| 18 Mar 2011 | State Bank Of India | ₹9.00 Cr | Open |
| 14 Dec 2010 | State Bank Of India | ₹3.20 Cr | Open |
How Many Employees Work at Sri Ganapathi Drug Intermediates?
Unlock and access historical data on people associated with Sri Ganapathi Drug Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Ganapathi Drug Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Ganapathi Drug Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sri Ganapathi Drug Intermediates
Recent activity within the organization
- Annual General Meeting
Sri Ganapathi Drug Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Sri Ganapathi Drug Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Sai Rakshith Thatikonda was appointed as a Director was appointed as a Director on 03 Jul 2023 & has been associated with this company since 1 year 10 months .
- Charges
A charge with State Bank Of India amounted to Rs. 2.25 Cr with Charge ID 100034734 was registered on 19 May 2016.
- Director Appointment
Venkata Purnachandra Rao Jogi was appointed as a Additional Director was appointed as a Additional Director on 30 Mar 2015 & has been associated with this company since 10 years 1 month .
- Charges
A charge with State Bank Of India amounted to Rs. 9.00 Cr with Charge ID 10425145 was registered on 18 Apr 2013.
Frequently asked questions
What is the Incorporation or founding date of Sri Ganapathi Drug Intermediates Private Limited?
Sri Ganapathi Drug Intermediates Private Limited was incorporated on 10 Sep 2010.
What is authorized share capital and paid-up capital of Sri Ganapathi Drug Intermediates Private Limited?
The authorized share capital of Sri Ganapathi Drug Intermediates Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.25 Cr.
Who are the current board members & directors of Sri Ganapathi Drug Intermediates Private Limited?
Currently 3 directors are associated with Sri Ganapathi Drug Intermediates Private Limited.
- Koti Reddy Tatikonda
- Venkata Purnachandra Rao Jogi
- Sai Rakshith Thatikonda
What is the registered address of Sri Ganapathi Drug Intermediates Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sri Ganapathi Drug Intermediates Private Limited is Plot.No 8-3-214/51 4Th Floor India, Ameerpet, Telangana, 500038.
What is the corporate identification number (CIN) and company number of Sri Ganapathi Drug Intermediates Private Limited?
The corporate identification number (CIN) of Sri Ganapathi Drug Intermediates Private Limited is U24232TG2010PTC070402 and the company number is 070402 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Sri Ganapathi Drug Intermediates Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Sri Ganapathi Drug Intermediates Private Limited has fallen by -19.95%.
What change has been observed in the net worth of Sri Ganapathi Drug Intermediates Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Sri Ganapathi Drug Intermediates Private Limited has experienced an downturn of -0.72%.
What are the total open charges for Sri Ganapathi Drug Intermediates Private Limited?
As per the financial statements for fiscal Year 2020, The total open charges for Sri Ganapathi Drug Intermediates Private Limited amount to ₹ 23.45 Cr.
When was the last Balance Sheet of Sri Ganapathi Drug Intermediates Private Limited filed with the ROC?
The most recent Balance Sheet for Sri Ganapathi Drug Intermediates Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
GK
Gurunatharao KalavapallyDirector
Similar Companies Based on Chemical Distribution & Retail
Tegral India Private Limited Mumbai, Maharashtra, India
Klj Resources Ltd Kolkata, West Bengal, India
Sanjay Chemicals (India) Private Limited Mumbai, Maharashtra, India
Pon Pure Chemical India Private Limited Chennai, Tamil Nadu, India
Signet Excipients Private Limited Mumbai, Maharashtra, India
Reliance Ethane Pipeline Limited Ahmedabad, Gujarat, India
Sharda Cropchem Limited Mumbai, Maharashtra, India
Hazel Mercantile Limited Mumbai, Maharashtra, India